Skip to content
Acredit

Acredit

  • The Acredit Network
  • About ACREDIT
    • About ACREDIT
    • CMOR
    • Translational Cancer Therapy
    • Ahus Gastrointestinal Radiology (Gastrorad) Research Group
    • Image guided surgery and minimal intervention
    • Clinical and translational cancer research
    • Vacancies
  • About Colorectal Cancer
  • News
  • Research
    • METIMMOX
    • The LARC-RRP study
    • LARC-EX study
    • The OSLO-CoMet study
    • The ImmunoPeCa study
    • The OxyTarget study
    • The MetAction study
    • The EuroPMP COST Action
    • Cure4PMP
    • The PRAVO study
    • The Bone Marrow Micrometastasis in Colorectal Cancer study
  • Privacy Policy
  • Contact Information
Acredit
News 

Metimmox Featured in Onkonytt

13/02/201804/11/2019 acredit colorectal cancer, Metimmox

Our very own Anne Hansen Ree has been featured in a recent issue of Onkonytt. In it, Anne tells the story of the new Metimmox study that the Acredit Network will be undertaking.

To read the article (in Norwegian), click here.

To find out more about the Metimmox trial, click here.

  • ← New Research Into Rectal Cancer
  • MetAction in the News →

Tag Cloud

Acredit angiogenesis award Biobanking biomarkers Blood Vessels chemotherapy circulating biomarkers colorectal cancer COST Disputas durable response ESTRO exosome extracellular vesicles FLT3LG Graduation hypoxia immune system immunogenicity Immunotoxins Kreftforening LARC liver MetAction metastasis Metimmox miRNA MRI MSS mutation neoadjuvant oxaliplatin OxyTarget Peritoneal Metastasis PMP Precision Medicine Pseudomyxoma peritonei PSOGI radiation Rectal Cancer surgery T-Cells Tumour Aggresiveness Vitamin D
Copyright © 2023 Acredit. All rights reserved.
Theme: ColorMag by ThemeGrill. Powered by WordPress.